Antithymocyte immunoglobulin

Therapeutic indications

Antithymocyte immunoglobulin is indicated for:

Prophylaxis of graft rejection

Population group: both men and women, only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Steroid resistant graft rejection

Population group: both men and women, only adults (18 years old or older)

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Antithymocyte immunoglobulin is contraindicated in the following cases:

Infections